Insight Molecular Diagnostics (IMDX) Cash from Investing Activities Growth (1y) (2016 - 2026)
Insight Molecular Diagnostics (IMDX) Cash from Investing Activities Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 156.94% |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | -3,832.95% |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | -165.43% |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 32.46% |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | -10.12% |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 24.18% |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | -148.98% |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 95.92% |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | -289.16% |
| 10 | Insight Molecular Diagnostics | 158.03 Mn | 139.50 Mn | 157,000.00 | -123.21% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -123.21% |
| Mar 31, 2026 | -99.67% |
| Dec 31, 2025 | -604.29% |
| Sep 30, 2025 | -1,106.90% |
| Jun 30, 2025 | -82.72% |
| Mar 31, 2025 | -1,179.17% |
| Dec 31, 2024 | -303.88% |
| Sep 30, 2024 | -140.65% |
| Jun 30, 2024 | -255.28% |
| Mar 31, 2024 | 98.25% |
| Dec 31, 2023 | 112.84% |
| Sep 30, 2023 | 124.91% |
| Jun 30, 2023 | 111.00% |
| Mar 31, 2023 | 12.11% |
| Dec 31, 2022 | -100.00% |
| Sep 30, 2022 | -118.02% |
| Jun 30, 2022 | 77.16% |
| Mar 31, 2022 | 81.13% |
| Dec 31, 2021 | 19.48% |
| Sep 30, 2021 | 25.10% |